Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 127, pseudogene (RNU6-127P) is a human pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[1][2]. Unlike canonical U6 snRNA genes, pseudogenes such as RNU6-127P are generally considered non-functional due to mutations or deletions that prevent them from being processed into mature RNA molecules or participating in biological complexes like the spliceosome[2]. U6 snRNAs are essential components of the spliceosome, catalyzing pre-mRNA splicing, but the RNU6-127P pseudogene itself is not transcribed into a functional product and does not have a direct biological or therapeutic role[1][2][5]. Pseudogenes like RNU6-127P may be transcribed in some cases or have regulatory roles, though there is no evidence supporting such functions for this particular pseudogene[1][4]. No associated diseases, drug interactions, biomarker utility, or safety concerns are reported for RNU6-127P[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 127, pseudogene (RNU6-127P).